Live
- Pushpa 2 Hits ₹1000 Crore in 6 Days: How It Compares to Other Top Indian Films
- Vivo X200 and X200 Pro Launched in India: Price, Specifications, and Features
- Nitin Gadkari Admits Feeling Embarrassed at Global Summits Over Rising Road Accidents in India
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
- Mandal Level CM Cup Sports Concludes in Ija with Promising Talent and Enthusiastic Participation
- Harish Rao Slams Revanth Reddy: "More Talk, Less Action"
- Revolutionising Oil and Gas: Gaurav Kumar Sinha’s AI-Driven Innovations Transforming Efficiency and Profitability
Kurapati Krishnaiah is new CEO of Basavatarakam Indo-American Cancer Hospital & Research Institute
The Basavatarakam Indo-American Cancer Hospital and Research Institute here on Tuesday announced the appointment of Dr Kurapati Krishnaiah as its new Chief Executive Officer
Hyderabad : The Basavatarakam Indo-American Cancer Hospital and Research Institute here on Tuesday announced the appointment of Dr Kurapati Krishnaiah as its new Chief Executive Officer.
A distinguished orthopaedic surgeon with over 40 years of experience, Dr Krishnaiah brings a wealth of expertise to his new role, a release said. Welcoming Dr Krishnaiah, the Chairman Nandamuri Balakrishna and trustees of Basavatarakam Hospital spoke of his leadership, citing his exceptional track record in elevating healthcare standards and fostering research collaborations.
In addition to his clinical expertise, Dr Krishnaiah has made significant contributions to medical research, the release said. Dr Krishnaiah said : "It is an honour to lead an institution renowned for its commitment to cancer care. I am excited to collaborate with the team here to further enhance patient care, advance research, and continue the legacy of excellence."
